This article is a summary of our new analysis and proposal for reform of the drug policy in Bulgaria. What did we find out? The analysis covers 56% of health-insured persons and 40% of the funds reimbursed by the NHIF and includes 4 groups of diseases: cardiovascular, malignant tumors, diabetes mellitus and rheumatoid. In 2016, over 2.5 million health-insured …

More »